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Abstract 
Background: The benefits of using navigation technology for percutaneous local ablation of 
selected hepatocellular carcinoma (HCC) have been shown. Due to additional efforts in the 
procedural workflow, barriers to introducing navigation systems on a broad clinical level 
remain high. In this work, initial steps toward a novel concept for simple and precise targeting 
of HCC are evaluated. 
Methods: The proposed technique is based on an angiographic approach using an intrahepatic 
electromagnetic (EM) reference, for consecutive percutaneous navigated positioning of 
ablation probes. We evaluated the environmental influence of the angiography suite on EM 
tracking accuracy, the measurement of a 3D offset from two 2D fluoroscopy images, and the 
accuracy and efficiency of the proposed approach in a porcine liver model. 
Results: The C-arm had a major influence on EM tracking accuracy, with an error up to 3.8 
mm. The methodology applied for measurement of a 3D offset from 2D fluoroscopy images 
was confirmed to be feasible with a mean error of 0.76 mm. In the porcine liver model 
experiment, the overall target positioning error (TPE) was 2.0 mm and time for navigated 
targeting was 17.9 seconds, when using a tracked ablation probe. 
Conclusion: The initial methodology of the proposed technique was confirmed to be feasible, 
introducing a novel concept for simple and precise navigated targeting of HCC. 
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Introduction 
Local ablation represents an established low-morbidity and tissue-sparing treatment option for 
selected patients with hepatocellular carcinoma (HCC) (1,2), inducing local destruction of 
tumor cells through the delivery of heat by radiofrequency or microwaves. An important and 
challenging factor influencing the quality of ablative therapy is the adequate intrahepatic 
localization of tumors and the accurate placement of ablation probes in order to achieve 
adequate ablation zones (3). When relying on conventional ultrasound guidance, alterations in 
underlying liver tissue in patients with HCC may render visualization of tumors difficult, and 
radiation exposure may rise significantly when relying on computed tomography (CT) 
guidance (4). 
To address this challenge and increase precision of liver tumor ablation, image-guidance 
systems have been introduced with first reports confirming enhanced precision, efficiency and 
safety of percutaneous navigated ablation of liver tumors (5). Most existing navigation 
systems rely on the registration of pre- or intra-operative image data to the patient and organ 
position, a process which might introduce inaccuracies due to displacement of the target 
relative to the tracked reference marker during or after the registration process. Furthermore, 
most systems use optical tracking for instrument guidance (5,6), assuming tool rigidity 
beyond the tracked markers. This potentially leads to tracking errors at the tip of long or thin 
instruments prone to bending, and renders the tracking of flexible instruments such as 
angiographic catheters impossible. 
To overcome these limitations, electromagnetic (EM) tracking, which is functional through 
the human body, has been proposed as an alternative (7,8). Due to their small size, EM 
sensors can be integrated directly in the tip of instruments, avoiding tracking errors due to 
instrument bending and enabling the tracking of flexible instruments. Nevertheless, accuracy 
of EM tracking is influenced by ferromagnetic equipment in the proximity of the EM field, 
which must be evaluated and quantified in each specific clinical setting in order to ensure an 
optimal navigation environment (7). In the context of liver tumor ablation, various EM-based 
navigation approaches have been proposed, either using CT based image-to-patient 
registration by digitizing skin fiducials with an EM tracked pointer (9,10) or using 
intraoperative imaging in combination with a registration phantom (11,12). To date, various 
commercial navigation systems utilizing EM tracking for the ablation of liver tumors are 
available. While some are based on ultrasound imaging (e.g. eTRAX, CIVCO Medical 
Solutions, Kalona, Iowa, U.S.), others use CT data in combination with a field generator 
directly placed on the patient (e.g. IMACTIS, La Tronche, France). 
Regardless of the applied tracking technology, the interruption of the clinical workflow, 
due to supplementary procedural steps (registration, calibration), and additional financial 
efforts represent barriers to introducing navigation technology on a large clinical scale. 
Although a consistent system design contributes to the reduction of such costs (7), these 
aspects must be weighed against the expected clinical benefits (safety and reduced recurrence 
rates due to enhanced precision) and savings due to a more reproducible and potentially faster 
overall workflow. 
To address the challenge of precise targeting of liver tumors while reducing the complexity 
of the procedure to a minimum, we propose a novel concept for navigated free-hand targeting 
of HCC. Taking advantage of the benefits of EM tracking and the typical arterial blood supply 
of HCC lesions, we aim to integrate this technology such as to be independent from any 
explicit registration process and its potential sources of errors, by tracking the tumor at its 
very origin. In a clinical setting, the proposed technique would imply a transarterial access for 
placement of an intrahepatic EM reference for consecutive percutaneous navigated free-hand 
positioning of equally tracked ablation probes. 
In this work, we aim to evaluate initial steps towards the proposed technique, by 
investigating i) the environmental influence of the angiography suite on EM tracking 
accuracy, ii) the measurement of a 3D offset from two 2D fluoroscopy images, without an 
explicit registration, and iii) the accuracy and efficiency of the proposed approach in a porcine 
liver model. 
Materials and Methods 
EM tracking tools 
An existing mobile navigation cart (CAS-One Vario, CAScination, Bern, Switzerland) was 
equipped with EM tracking (Aurora, NDI, Waterloo, Ontario, Canada) and integrated into an 
angiography suite, containing a ceiling-mounted C-arm (Artis Zee, Siemens, Erlangen, 
Germany). 
A window field generator (WFG, NDI Aurora) with a wide opening (368 × 400 mm) and a 
carbon fiber outer structure was used (13), generating an electromagnetic cylindrical 
workspace (500 mm in diameter and 600 mm height). The WFG was mounted under the 
angiography table, which equally consists of carbon fiber (Figure 1). The coordinate systems 
of the EM field generator and the C-arm were aligned by attaching the rectangular WFG 
parallel to the angiography table with the aid of a water level, to allow a direct relationship 
between the measurements performed from the angiography images and the coordinates 
entered into the tracking system. 
 
Figure 1. Experimental setup in the angiography suite. 
As tracking reference, the smallest available NDI sensor (5DoF, 0.3 mm × 8 mm) was 
integrated into the tip of an angiographic wire. For targeting, a microwave ablation probe 
(Acculis MTA System, Queensbury, New York, U.S.) was equipped with an EM sensor (NDI, 
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5DoF, 0.5 mm × 8 mm), which was externally bonded approximately 14 mm behind the tip of 
the ablation probe using cyanoacrylate. As an alternative, a 6DoF EM-tracked trocar (Fiagon, 
Hennigsdorf, Germany) was used for guided insertion of ablation probes without attached EM 
sensors. The 5DoF EM sensors were aligned with the tools such that the missing 6th DoF 
aligned with the tool rotational axis. 
All tools were pre-calibrated by pivoting, a calibration method which estimates the center 
of a rotation. To this end, the tools were rotated around the tip and the sensor data were 
recorded, allowing to calculate the position of the tip (center of rotation) relative to the 
integrated sensor (14). To reduce jitter and flickering of the tracking signals, the reference 
sensor position was filtered by a simple moving average filter over the last 20 positions. Since 
the tracking accuracy varies within the electromagnetic field (13,15), all experiments were 
conducted in the clinically most feasible region of the field (centered, approximately 10 cm 
above the table). 
Experimental design and assessments 
Evaluation of environmental influence on EM tracking accuracy 
To quantify the influence of the angiography table and C-arm on EM tracking accuracy, a 
setup consisting of a fixed configuration of six 5DoF sensors (NDI, 0.5 mm × 8 mm) attached 
to a cube (side lengths 100 mm), with two sensors pointing toward each axis of the EM field, 
was used. 
To evaluate the influence of the angiography table, the distances for each pair of sensors 
(15 distances in total, ranging from 45 mm to 122 mm) were computed in three series of 100 
frames as baseline measurements. The same measurements were performed with the setup on 
the angiography table with the WFG underneath and the entire ceiling-mounted C-arm at 
maximum distance (190 cm horizontal distance from the center of the WFG). The absolute 
difference between these measurements to the mean distances of the baseline measurement 
were calculated and considered as errors. 
To evaluate the influence of the C-arm, the same setup was placed in the center of the EM 
field, and measurements performed with the entire ceiling-mounted C-arm at a maximum 
distance (190 cm horizontal distance from the center of the WFG) as baseline measurements. 
The entire C-arm was then moved stepwise towards the field generator in steps of 10 to 
20 cm, with measurements at each position. 
Evaluation of 3D offset measurement from 2D images 
As the tip of the catheter (i.e. the EM reference) cannot be placed directly in the center of the 
tumor target in a clinical situation, the measurement of an offset between the actual position 
of the catheter tip when placed in a tumor-supplying artery and the center of the tumor target 
becomes necessary (Figure 2(a)). This targeting offset was measured from two orthogonal 2D 
fluoroscopic images taken at 0° and 90°, with the C-arm aligned such that the region of 
interest was positioned on its isocenter (Figure 2(b)). 
As the WFG was pre-aligned with the angiography table, the offsets in the images could be 
measured and directly related to the XYZ coordinates of the tracking system and set in the 
navigation software. In the 0° image (Figure 2(b) top), the horizontal distance between tumor 
center (defined by the center of the circle) and catheter tip corresponds to the X offset, while 
the vertical distance corresponds to the Y offset. Accordingly, in the 90° image (Figure 2(b) 
bottom), the horizontal distance corresponds to the Z offset and the vertical distance again to 
the Y offset. The average of the Y offsets from both images was used if these values differed. 
To allow this direct accordance, the acquisition of the images at exactly 0° and 90° is 
essential. 
 
Figure 2. (a) Schematic illustration indicating a microcatheter in tumor-supplying artery of 
HCC. Overlaid are ablation probes for baseline targeting (green) and offset targeting 
(orange). (b) Measurement of the XYZ offset between the reference (tip of the catheter) and 
the target (center of the tumor) in 0° and 90° fluoroscopic images. 
To evaluate the accordance of the 3D offset measurements with the measurements from the 
EM system, two 5DoF EM sensors were placed in a cubic foam block (side lengths 140 mm) 
at fixed distances and placed onto the angiography table. Offset measurements from the 
images between the two sensors were then compared to the direct EM system measurement. 
To avoid any influence from the C-arm on the EM measurements, the entire ceiling-mounted 
C-arm was again moved to the maximum distance (190cm) from the area of EM 
measurement. 
Evaluation of targeting accuracy in porcine liver model 
For navigated targeting, the software uses the tracking information from two tools: the 
position of the catheter tip considered as the reference, and the position and orientation of a 
tracked ablation probe as the targeting device. It displays the relative 3D displacement of the 
probe with respect to the chosen target, with the information separated into orientation and 
distance. The orientation represented in a crosshair indicates the lateral distance and a depth 
bar the longitudinal distance (Figure 3(a)). 
The differential position of the probe and the tumor target as displayed on the navigation 
system is computed as 
𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇
𝑃𝑃𝑇𝑇𝑇𝑇𝑃𝑃𝑃𝑃 = −𝑇𝑇𝐶𝐶𝐶𝐶𝐶𝐶ℎ𝑃𝑃𝐶𝐶𝑃𝑃𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 − 𝑇𝑇𝐶𝐶𝐶𝐶𝐶𝐶ℎ𝑃𝑃𝐶𝐶𝑃𝑃𝑇𝑇 + 𝑇𝑇𝑃𝑃𝑇𝑇𝑇𝑇𝑃𝑃𝑃𝑃 
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position of the tracked catheter tip and 𝑇𝑇𝑃𝑃𝑇𝑇𝑇𝑇𝑃𝑃𝑃𝑃 the position and orientation of the tracked 
ablation probe, the latter two values as measured by the EM tracking (Figure 3(b)). 
 
Figure 3. (a) Concept of a crosshair viewer with longitudinal and lateral distances, and (b) 
transformations involved for the offset targeting. 
For the experimental model, artificial tumors (15 to 20 mm in diameter) consisting of 
agarose and contrast agent, creating a soft consistency similar to the surrounding liver 
parenchyma (16), as well as the reference EM sensor were placed between the liver lobes of 
an ex vivo porcine liver. This model was placed inside a closed torso and positioned on the 
angiography table (Figure 4(a, b)). Targeting of artificial tumors was performed free-hand 
under continuous visual guidance by the navigation system, in two different scenarios 
(Figure 2(a)). To evaluate technical accuracy of the navigation system in the proposed 
angiographic setting without any additional steps such as offset measurement and imaging 
involved, the tip of the EM reference was directly targeted (referred to as baseline targeting). 
To assess accuracy of the technique in a clinically relevant setting with an offset between the 
catheter tip and the tumor, the center of the tumor was targeted (referred to as offset 
targeting). 
Both baseline and offset targeting attempts were performed using i) the ablation probe with 
externally bonded EM sensor, and ii) an ablation probe without attached EM sensor inserted 
through an EM-tracked trocar (Figure 4(c)). As the ablation probe without attached EM 
sensor allowed only indirect depth control, the distance between the tracked trocar and the 
target as displayed by the EM navigation system was manually controlled by visual inspection 
of the marks on the probe. The entire ceiling-mounted C-arm was moved at a maximum 
distance (190 cm) from the area of interest during the navigated targeting attempts, to avoid 
any influence from the C-arm onto the EM tracking accuracy. 
Once the ablation probe was positioned, targeting accuracy was assessed as target 
positioning error (TPE), expressing the Euclidean distance between the defined target and the 
tip of the targeting tool (17) as measured in the fluoroscopy images. Additionally, time for 
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navigated targeting was manually assessed using a stopwatch, measuring time from insertion 
of the ablation probe to reaching the final position. 
 
Figure 4. (a) Set-up of the closed torso and the navigation system, (b) the porcine liver inside 
the open torso, (c) EM tracked instruments (from left to right): EM-tracked catheter used as 
reference, ablation probe without attached EM sensor, ablation probe with externally bonded 
EM sensor, EM tracked trocar. 
Data analysis 
The TPE in the fluoroscopic images were measured in OsiriX (Pixmeo, Bernex, Switzerland) 
and processed using Matlab (MathWorks, Natick, Massachusetts, U.S.). Statistical analyses 
were performed applying the two-tailed, two-sample t-test with a significance level of 
α = 0.05, using Prism (GraphPad Software, Inc., La Jolla, California, U.S.). 
Results 
Evaluation of environmental influence on EM tracking accuracy 
The influence of the angiography table resulted in a mean error of 0.77 mm when compared to 
baseline measurements (95% confidence interval (CI95) 0.64–0.90 mm, n = 3 × 15 = 45). 
The influence of the C-arm showed tracking errors starting to increase at a distance of 
110 cm and reaching a maximum of 3.8 mm when the detector of the C-arm is above the 
WFG (Figure 5). Errors were strongly dependent on the orientation of the sensors, with the 
two sensors oriented in Z direction showing the largest changes in position. 
 
Figure 5. Influence of the C-arm distance on EM tracking errors. The distance of 0 cm 
indicates the C-arm centered over the EM field generator. 
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Evaluation of 3D offset measurement from 2D images 
In total, five measurements were performed with the two EM sensors at different distances 
from each other (ranging from 9 mm to 100 mm). Median values for the X and Y differences 
(0.31 mm and 0.23 mm) were lower than those from the Z differences (0.59 mm), with the 
Euclidean differences (0.76 mm, interquartile range 0.49 mm) subsequently dominated by this 
Z error component. 
Evaluation of targeting accuracy in porcine liver model 
Twelve baseline and twelve offset targeting attempts (offset of 47 mm, Euclidean distance) 
were performed using the EM tracked ablation probe. Additionally, twelve baseline and 
twenty-four offset targeting attempts (twelve each with an offset of 46 mm and 92 mm, 
Euclidean distances) were performed using the ablation probe without attached EM sensor 
with the EM-tracked trocar. 
Figure 6(a) summarizes TPEs grouped by targeting type (baseline vs. offset) and by 
targeting modality (ablation probe vs. trocar). The mean TPE using the ablation probe was 
lower for the baseline attempts (1.7 mm, CI95 0.9–2.6 mm) compared to the offset attempts 
(2.2 mm, CI95 1.4–3.0 mm). A similar trend was observed using the trocar with a mean TPE 
of 2.2 mm (CI95 1.0–3.3 mm) for baseline and 2.7 mm (CI95 2.0–3.3 mm) for offset attempts. 
Moreover, the targeting attempts using the tracked trocar were less accurate compared to the 
attempts using the ablation probe, particularly when performing offset targeting (2.7 mm and 
2.2 mm respectively). None of the differences between the various groups were statistically 
significant, and no relationship was observed between the two different offsets (46 mm and 
92 mm) and the resulting mean TPEs for the offset attempts using the tracked trocar (both 
2.7 mm, n=12 each). Two exemplary attempts of baseline and offset targeting are shown in 
Figure 6(b, c). 
Mean targeting time for the targeting attempts using the EM tracked ablation probe was 
17.9 seconds (CI95 14.1–21.6 seconds, range 5–43°seconds), while targeting times for 
attempts using the tracked trocar were significantly longer (mean 27.4 seconds, CI95 24.1–
30.7 seconds, range 15–58 seconds) (p < 0.001). 
 
 
Figure 6. (a) Summary of the target positioning errors (TPE) from all 60 targeting attempts. 
Means and 95% confidence intervals are shown. (b) Baseline and (c) offset targeting attempts 
using the ablation probe with externally bonded EM sensor. 
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Discussion 
In this work, we present initial steps toward a novel technique for precise ablation of liver 
tumors, implying an angiographic approach for endovascular placement of an EM reference 
sensor and consecutive percutaneous navigated tumor targeting. Methodological feasibility, 
positional accuracy and procedural efficiency of the technique were confirmed in a series of 
ex vivo experiments. 
First analyses assessed the influence of involved objects within the angiography suite on 
EM tracking accuracy and thus the functionality of EM tracking within the desired clinical 
environment. The influence of the angiography table was negligible, however, a significant 
influence of the C-arm on tracking accuracy was observed, with an increasing measurement 
error at distances below 110 cm between the C-arm and the WFG. Hence, all following EM 
measurements were performed with the entire ceiling-mounted C-arm at maximum distance to 
minimize the influence on tracking accuracy. 
The small differences between 3D offset measurements from 2D images and EM tracking 
(0.76 mm) confirm the feasibility of the proposed methodology of measuring a 3D offset from 
two 2D fluoroscopic images. This finding is further underlined when comparing the accuracy 
of the baseline and offset targeting attempts in the porcine liver model. Baseline targeting 
aimed to assess the basic performance of the proposed technique when using the EM tracking 
system for targeting in a “best case scenario”, without an additional offset measurement. This 
allowed to gain knowledge about the specific influence of the proposed 3D offset 
measurement on the targeting error. Accordingly, the difference of 0.5 mm between the 
average TPE from baseline and offset targeting confirmed a minimal influence of the 
proposed offset measurement technique on targeting accuracy. Most importantly, the 
proposed method of 3D offset measurement allows for navigated targeting of the tumor center 
relying only on intraoperative imaging. Hence, a possible loss of targeting accuracy due to 
registration errors can be avoided, the latter representing a frequent and relevant limitation of 
registration-based navigation (9,10). 
The above evaluations implicitly confirm the correct mounting of the WFG under the 
angiography table, since a misalignment would lead to higher differences between 3D offset 
measurements from 2D images and EM tracking. Furthermore, no relevant occlusions due to 
the field generator occurred in the images, as the WFG is explicitly constructed for the use in 
an angiographic environment. However, low levels of random white noise were observed in 
the 0° C-arm images, when the EM field generator was switched on. Nevertheless, no image 
distortion was observed, and the needles and catheters were clearly visible. 
In all experiments, the average targeting accuracy (measured as TPE) was below 3 mm. 
Although this obviously needs to be confirmed in vivo, this accuracy would lie within a 
favorable and acceptable range for targeting and ablation of HCC, when aiming at an 
additional safety margin of 5–10 mm (3,18,19). In another work, targeting errors of 
6.4 ± 3.3 mm (n = 76) and 8.3 ± 3.7 mm (n = 32) have been reported in phantom experiments 
and in vivo, respectively (9). Levy et al. applied CT-based image-to-patient registration by 
digitizing skin fiducials using an EM tracked pointer, with an additional EM tracked 
intrahepatic needle serving as reference to detect organ motion, and propose the use of 
multiple internal fiducials to further enhance the accuracy of the system (10). In our proposed 
technique, an EM tracked reference is placed in immediate proximity to the intrahepatic 
tumor target, thus allowing a synchronous motion of both the tracked reference and target, 
allowing navigated targeting without an explicit registration. 
As expected, the use of a directly tracked ablation probe resulted in higher targeting 
accuracy than the combination of an ablation probe without attached EM sensor inserted 
through a tracked trocar. This is likely due to unintended instrument bending as well as the 
more complex handling of the tracked trocar due to indirect depth control. This confirms that 
direct tracking of the ablation probe close to the tip of the targeting instrument allowed 
enhanced targeting accuracy, as has been previously described (20). 
The proposed targeting procedure was efficient with an average targeting time of 
17.9 seconds (CI95 14.1–21.6 seconds) in the porcine liver experiment. Although the time 
needed for offset measurement itself was not explicitly assessed, metadata of the fluoroscopic 
images indicate a duration of around 5 minutes. This offset measurement could be easily 
accelerated using a more dedicated software alternatively to the C-arm console used for our 
experiments. 
To adapt the proposed approach toward an eventual clinical application, the 
instrumentation applied in this work would need further development. For the intrahepatic 
placement of an endovascular reference, an EM-tracked angiographic wire adapted to the 
dimensions of a clinically applicable microcatheter as used for hepatic interventions (e.g. 
2.7 French) would be required. While various attempts to integrate EM sensors into 
angiographic catheters and guidewires have been presented (12), no EM-tracked wire with the 
required dimensions is currently available. To this end, a prototype of an EM-tracked 
angiographic wire is currently developed by our team. Furthermore, to the best of our 
knowledge no ablation probes with directly integrated EM sensors are available to date, 
although clinical tests with externally bonded sensors have been conducted previously (21). 
Next to these more technical elements, various workflow related issues need further 
investigation towards the integration of the proposed method into a clinical application. 
Although all experiments were conducted in the relevant region of the EM field (centered, 
approximately 10 cm above the table), higher inaccuracies might occur if the patient cannot 
be positioned as anticipated, since the accuracy within the EM field is not homogeneous 
(13,15). To confirm the accurate needle placement and to detect a potential dislocation of the 
reference sensor between offset measurement and targeting, a control image would have to be 
acquired between needle placement and the actual treatment. Furthermore, as the proposed 
workflow is focused on a directly tumor-targeted approach using dynamic tracking of the 
tumor at its origin, additional path planning along the needle trajectory between skin incision 
and liver would become necessary in a clinical application. In the presented 2D angiographic 
setting, ultrasound guidance would be a simple and previously described method (22); 
alternatively the use of cone beam CT could potentially optimize path planning as well as 
offset measurement for the proposed technique (23). 
In a clinical setting, the proposed transarterial approach would obviously represent an 
additional invasive access for percutaneous ablation, which could however be beneficial when 
applied in a combined approach of ablation and transarterial chemo-embolization (TACE), 
where selective catheterization of the tumor-supplying arteries is already performed. Such a 
combined approach has been shown benefits regarding oncological outcome in selected 
patients with HCC (24–26). Moreover, the proposed principle (i.e. placing an EM-tracked 
reference in the immediate vicinity of the target structure to bring an EM-tracked instrument 
into this target structure) represents a generic electromagnetic navigation approach, which 
might be beneficial in various other medical applications. Since we demonstrated that 2D 
fluoroscopy is a simple imaging modality leading to accurate targeting within the proposed 
technique, this could also be applied in other domains where mostly mobile C-arms are 
available, e.g. in OR-based fluoroscopy. 
Conclusion 
The initial methodology of a novel concept for targeting and ablation of liver tumors using 
EM navigation in an angiographic setting was demonstrated, allowing precise and efficient 
targeting in a porcine liver model without the need for an explicit registration process. These 
initial results will allow the further evaluation of the proposed technique toward a clinical 
application in vivo. 
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